Document is current

Any future updates will be listed below

A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation

Crossref DOI link: https://doi.org/10.1007/s00125-014-3296-7

Published Online: 2014-06-25

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark